Pembrolizumab-induced optic neuropathy – a case report

BACKGROUND: Immune checkpoint inhibitor (ICI) treatment has become important for treating various cancer types, including Hodgkin’s lymphoma. However, ICI can overstimulate the immune system, leading to a broad range of immunological side effects, known as immune-related adverse events (irAEs). Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Daetwyler, Eveline, Zippelius, Alfred, Meyer, Peter, Läubli, Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203429/
https://www.ncbi.nlm.nih.gov/pubmed/37228591
http://dx.doi.org/10.3389/fimmu.2023.1171981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203429/
https://www.ncbi.nlm.nih.gov/pubmed/37228591
http://dx.doi.org/10.3389/fimmu.2023.1171981

Ejemplares similares